Physician profile
Stephen B Riggs
NPI 1659393718
$4,900.33
in general payments reported to CMS, 2019-2025
10 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $2,169 · 2021: $113 · 2022: $176 · 2023: $390 · 2024: $1,474 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,061 · Food and Beverage: $877 · Education: $75.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,060.90 |
| Food and Beverage | $876.78 |
| Education | $75.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,144.00 | 2020 | |
| Medtronic, INC. | $1,290.24 | 2024 | |
| Boston Scientific Corporation | $781.33 | 2019-2025 | Lithovue |
| Ethicon US, LLC | $254.70 | 2020-2025 | Echelon Endopath, Echelon; Endopath, Vistaseal |
| Intuitive Surgical, INC. | $207.45 | 2021-2023 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $74.72 | 2019 | |
| Urogen Pharma, INC. | $59.04 | 2024 | |
| Astellas Pharma US INC | $34.80 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $31.00 | 2021 | |
| Coloplast Corp | $23.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Riggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.